{"id":"vitamin-d-liquid-form-start-monthly","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypercalcemia"},{"rate":null,"effect":"Hypercalciuria"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Weakness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vitamin D (cholecalciferol or ergocalciferol) is converted in the liver and kidneys to its active form, calcitriol (1,25-dihydroxyvitamin D3), which binds to the vitamin D receptor (VDR) in target tissues. This activates gene transcription involved in calcium absorption in the intestine, bone mineralization, immune regulation, and cellular proliferation and differentiation. The monthly liquid formulation provides convenient dosing for vitamin D supplementation or replacement therapy.","oneSentence":"Vitamin D acts as a steroid hormone that binds to vitamin D receptors to regulate calcium and phosphate homeostasis, immune function, and cell differentiation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:15:25.884Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Vitamin D deficiency supplementation"},{"name":"Hypocalcemia management"},{"name":"Osteoporosis prevention and treatment"},{"name":"Hypoparathyroidism"}]},"trialDetails":[{"nctId":"NCT03141593","phase":"PHASE4","title":"Oral Vitamin D Substitution Weekly or Monthly and Adherence","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2017-10-09","conditions":"Vitamin D Deficiency","enrollment":97}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Vi-De 3 Monatsdosis"],"phase":"marketed","status":"active","brandName":"Vitamin D: liquid form, start monthly","genericName":"Vitamin D: liquid form, start monthly","companyName":"University Hospital, Basel, Switzerland","companyId":"university-hospital-basel-switzerland","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vitamin D acts as a steroid hormone that binds to vitamin D receptors to regulate calcium and phosphate homeostasis, immune function, and cell differentiation. Used for Vitamin D deficiency supplementation, Hypocalcemia management, Osteoporosis prevention and treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}